Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

PURPOSE: Clinical trials have demonstrated the favorable efficacy/safety profile of pasireotide in patients with Cushing’s disease (CD). We report interim long-term results of an ongoing real-world evidence study of subcutaneous pasireotide in patients with CD. METHODS: Adults with CD receiving pasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Manetti, Luca, Deutschbein, Timo, Schopohl, Jochen, Yuen, Kevin C. J., Roughton, Michael, Kriemler-Krahn, Ulrike, Tauchmanova, Libuse, Maamari, Ricardo, Giordano, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728293/
https://www.ncbi.nlm.nih.gov/pubmed/31440946
http://dx.doi.org/10.1007/s11102-019-00984-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728293/
https://www.ncbi.nlm.nih.gov/pubmed/31440946
http://dx.doi.org/10.1007/s11102-019-00984-6

Ejemplares similares